Global Heavy-duty Trucks On-board Diagnostics System Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	170 Pages	TechNavio	January, 2024	INF18455785

Best Price Guarantee
Price	from $2,500
Length	170 Pages
Publisher	TechNavio
Published Date	January, 2024
SKU	INF18455785

Global Heavy-duty Trucks On-board Diagnostics System Market 2024-2028

The heavy-duty trucks on-board diagnostics system market is forecasted to grow by USD 89.21 mn during 2023-2028, accelerating at a CAGR of 3.42% during the forecast period. The report on the heavy-duty trucks on-board diagnostics system market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by need for fleet operators to reduce total cost of ownership, adoption of usage-based insurance (ubi) models, and increasing volume of electronic content in modern vehicles.

Technavio's heavy-duty trucks on-board diagnostics system market is segmented as below:

By Vehicle Type

Class 8
Class 7

By Type

Hand-held scan tools
Mobile device based tools
PC-based scan tools

By Geographical Landscape

North America
APAC
Europe
South America
Middle East and Africa

This study identifies the emergence of truck platooning as one of the prime reasons driving the heavy-duty trucks on-board diagnostics system market growth during the next few years. Also, prognostic systems offer untapped revenue sources to commercial vehicle OEMs and growing popularity of fleet management solutions in the logistics sector will lead to sizable demand in the market.

The report on the heavy-duty trucks on-board diagnostics system market covers the following areas:

Heavy-duty trucks on-board diagnostics system market sizing
Heavy-duty trucks on-board diagnostics system market forecast
Heavy-duty trucks on-board diagnostics system market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading heavy-duty trucks on-board diagnostics system market vendors that include ACTIA Group, Autel Intelligent Technology Co., AVL DiTEST GmbH, Bridgestone Corp., CalAmp Corp., Continental AG, Cummins Inc., Danlaw Inc., Fleet Complete, Garrett Motion Inc., Geotab Inc., iWave Systems Technologies Pvt. Ltd., Moj.io Inc., OBD Solutions LLC, Robert Bosch GmbH, Snap On Inc., Vector Informatik GmbH, Vidiwave Ltd., ZF Friedrichshafen AG, and Zubie Inc.. Also, the heavy-duty trucks on-board diagnostics system market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Application; Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global exosome diagnostics and therapeutics market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global exosome diagnostics and therapeutics market 2018 - 2022 ($ million); 4.2 Application Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.3 End-user Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application: 6.1 Market segments; Exhibit 30: Chart on Application - Market share 2023-2028 (%); Exhibit 31: Data Table on Application - Market share 2023-2028 (%); 6.2 Comparison by Application; Exhibit 32: Chart on Comparison by Application; Exhibit 33: Data Table on Comparison by Application; 6.3 Diagnostic - Market size and forecast 2023-2028; Exhibit 34: Chart on Diagnostic - Market size and forecast 2023-2028 ($ million); Exhibit 35: Data Table on Diagnostic - Market size and forecast 2023-2028 ($ million); Exhibit 36: Chart on Diagnostic - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Diagnostic - Year-over-year growth 2023-2028 (%); 6.4 Therapeutic - Market size and forecast 2023-2028; Exhibit 38: Chart on Therapeutic - Market size and forecast 2023-2028 ($ million); Exhibit 39: Data Table on Therapeutic - Market size and forecast 2023-2028 ($ million); Exhibit 40: Chart on Therapeutic - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Therapeutic - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Application; Exhibit 42: Market opportunity by Application ($ million); Exhibit 43: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by End-user: 7.1 Market segments; Exhibit 44: Chart on End-user - Market share 2023-2028 (%); Exhibit 45: Data Table on End-user - Market share 2023-2028 (%); 7.2 Comparison by End-user; Exhibit 46: Chart on Comparison by End-user; Exhibit 47: Data Table on Comparison by End-user; 7.3 Research and academic institutes - Market size and forecast 2023-2028; Exhibit 48: Chart on Research and academic institutes - Market size and forecast 2023-2028 ($ million); Exhibit 49: Data Table on Research and academic institutes - Market size and forecast 2023-2028 ($ million); Exhibit 50: Chart on Research and academic institutes - Year-over-year growth 2023-2028 (%); Exhibit 51: Data Table on Research and academic institutes - Year-over-year growth 2023-2028 (%); 7.4 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028; Exhibit 52: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million); Exhibit 53: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million); Exhibit 54: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); 7.5 Commercial - Market size and forecast 2023-2028; Exhibit 56: Chart on Commercial - Market size and forecast 2023-2028 ($ million); Exhibit 57: Data Table on Commercial - Market size and forecast 2023-2028 ($ million); Exhibit 58: Chart on Commercial - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on Commercial - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by End-user; Exhibit 60: Market opportunity by End-user ($ million); Exhibit 61: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 65: Chart on Geographic comparison; Exhibit 66: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 UK - Market size and forecast 2023-2028; Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.10 China - Market size and forecast 2023-2028; Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%); 9.11 Japan - Market size and forecast 2023-2028; Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 103: Market opportunity By Geographical Landscape ($ million); Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 105: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 106: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 107: Overview on factors of disruption; 11.4 Industry risks; Exhibit 108: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 109: Vendors covered; 12.2 Market positioning of vendors; Exhibit 110: Matrix on vendor position and classification; 12.3 Aethlon Medical Inc.; Exhibit 111: Aethlon Medical Inc. - Overview; Exhibit 112: Aethlon Medical Inc. - Business segments; Exhibit 113: Aethlon Medical Inc. - Key offerings; Exhibit 114: Aethlon Medical Inc. - Segment focus; 12.4 Bio Techne Corp.; Exhibit 115: Bio Techne Corp. - Overview; Exhibit 116: Bio Techne Corp. - Business segments; Exhibit 117: Bio Techne Corp. - Key offerings; Exhibit 118: Bio Techne Corp. - Segment focus; 12.5 Capricor Therapeutics Inc.; Exhibit 119: Capricor Therapeutics Inc. - Overview; Exhibit 120: Capricor Therapeutics Inc. - Product / Service; Exhibit 121: Capricor Therapeutics Inc. - Key offerings; 12.6 Evox Therapeutics Ltd.; Exhibit 122: Evox Therapeutics Ltd. - Overview; Exhibit 123: Evox Therapeutics Ltd. - Product / Service; Exhibit 124: Evox Therapeutics Ltd. - Key offerings; 12.7 Hologic Inc.; Exhibit 125: Hologic Inc. - Overview; Exhibit 126: Hologic Inc. - Business segments; Exhibit 127: Hologic Inc. - Key news; Exhibit 128: Hologic Inc. - Key offerings; Exhibit 129: Hologic Inc. - Segment focus; 12.8 JSR Life Sciences LLC; Exhibit 130: JSR Life Sciences LLC - Overview; Exhibit 131: JSR Life Sciences LLC - Product / Service; Exhibit 132: JSR Life Sciences LLC - Key offerings; 12.9 Lonza Group Ltd.; Exhibit 133: Lonza Group Ltd. - Overview; Exhibit 134: Lonza Group Ltd. - Business segments; Exhibit 135: Lonza Group Ltd. - Key news; Exhibit 136: Lonza Group Ltd. - Key offerings; Exhibit 137: Lonza Group Ltd. - Segment focus; 12.10 Merck KGaA; Exhibit 138: Merck KGaA - Overview; Exhibit 139: Merck KGaA - Business segments; Exhibit 140: Merck KGaA - Key news; Exhibit 141: Merck KGaA - Key offerings; Exhibit 142: Merck KGaA - Segment focus; 12.11 Miltenyi Biotec B.V. and Co. KG; Exhibit 143: Miltenyi Biotec B.V. and Co. KG - Overview; Exhibit 144: Miltenyi Biotec B.V. and Co. KG - Product / Service; Exhibit 145: Miltenyi Biotec B.V. and Co. KG - Key offerings; 12.12 Nanosomix Inc.; Exhibit 146: Nanosomix Inc. - Overview; Exhibit 147: Nanosomix Inc. - Product / Service; Exhibit 148: Nanosomix Inc. - Key offerings; 12.13 NX PharmaGen Inc.; Exhibit 149: NX PharmaGen Inc. - Overview; Exhibit 150: NX PharmaGen Inc. - Product / Service; Exhibit 151: NX PharmaGen Inc. - Key offerings; 12.14 QIAGEN NV; Exhibit 152: QIAGEN NV - Overview; Exhibit 153: QIAGEN NV - Product / Service; Exhibit 154: QIAGEN NV - Key news; Exhibit 155: QIAGEN NV - Key offerings; 12.15 Sarepta Therapeutics Inc; Exhibit 156: Sarepta Therapeutics Inc - Overview; Exhibit 157: Sarepta Therapeutics Inc - Product / Service; Exhibit 158: Sarepta Therapeutics Inc - Key offerings; 12.16 System Biosciences LLC; Exhibit 159: System Biosciences LLC - Overview; Exhibit 160: System Biosciences LLC - Product / Service; Exhibit 161: System Biosciences LLC - Key offerings; 12.17 Thermo Fisher Scientific Inc.; Exhibit 162: Thermo Fisher Scientific Inc. - Overview; Exhibit 163: Thermo Fisher Scientific Inc. - Business segments; Exhibit 164: Thermo Fisher Scientific Inc. - Key news; Exhibit 165: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 166: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 167: Inclusions checklist; Exhibit 168: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 169: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 170: Research methodology; Exhibit 171: Validation techniques employed for market sizing; Exhibit 172: Information sources; 13.5 List of abbreviations; Exhibit 173: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Market Segmentation by End-user; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global exosome diagnostics and therapeutics market 2018 - 2022 ($ million); Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Application - Market share 2023-2028 (%); Exhibits31: Data Table on Application - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Application; Exhibits33: Data Table on Comparison by Application; Exhibits34: Chart on Diagnostic - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on Diagnostic - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on Diagnostic - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Diagnostic - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Therapeutic - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Therapeutic - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Therapeutic - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Therapeutic - Year-over-year growth 2023-2028 (%); Exhibits42: Market opportunity by Application ($ million); Exhibits43: Data Table on Market opportunity by Application ($ million); Exhibits44: Chart on End-user - Market share 2023-2028 (%); Exhibits45: Data Table on End-user - Market share 2023-2028 (%); Exhibits46: Chart on Comparison by End-user; Exhibits47: Data Table on Comparison by End-user; Exhibits48: Chart on Research and academic institutes - Market size and forecast 2023-2028 ($ million); Exhibits49: Data Table on Research and academic institutes - Market size and forecast 2023-2028 ($ million); Exhibits50: Chart on Research and academic institutes - Year-over-year growth 2023-2028 (%); Exhibits51: Data Table on Research and academic institutes - Year-over-year growth 2023-2028 (%); Exhibits52: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million); Exhibits53: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million); Exhibits54: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on Commercial - Market size and forecast 2023-2028 ($ million); Exhibits57: Data Table on Commercial - Market size and forecast 2023-2028 ($ million); Exhibits58: Chart on Commercial - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on Commercial - Year-over-year growth 2023-2028 (%); Exhibits60: Market opportunity by End-user ($ million); Exhibits61: Data Table on Market opportunity by End-user ($ million); Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits65: Chart on Geographic comparison; Exhibits66: Data Table on Geographic comparison; Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits92: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits93: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits103: Market opportunity By Geographical Landscape ($ million); Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits105: Impact of drivers and challenges in 2023 and 2028; Exhibits106: Overview on Criticality of inputs and Factors of differentiation; Exhibits107: Overview on factors of disruption; Exhibits108: Impact of key risks on business; Exhibits109: Vendors covered; Exhibits110: Matrix on vendor position and classification; Exhibits111: Aethlon Medical Inc. - Overview; Exhibits112: Aethlon Medical Inc. - Business segments; Exhibits113: Aethlon Medical Inc. - Key offerings; Exhibits114: Aethlon Medical Inc. - Segment focus; Exhibits115: Bio Techne Corp. - Overview; Exhibits116: Bio Techne Corp. - Business segments; Exhibits117: Bio Techne Corp. - Key offerings; Exhibits118: Bio Techne Corp. - Segment focus; Exhibits119: Capricor Therapeutics Inc. - Overview; Exhibits120: Capricor Therapeutics Inc. - Product / Service; Exhibits121: Capricor Therapeutics Inc. - Key offerings; Exhibits122: Evox Therapeutics Ltd. - Overview; Exhibits123: Evox Therapeutics Ltd. - Product / Service; Exhibits124: Evox Therapeutics Ltd. - Key offerings; Exhibits125: Hologic Inc. - Overview; Exhibits126: Hologic Inc. - Business segments; Exhibits127: Hologic Inc. - Key news; Exhibits128: Hologic Inc. - Key offerings; Exhibits129: Hologic Inc. - Segment focus; Exhibits130: JSR Life Sciences LLC - Overview; Exhibits131: JSR Life Sciences LLC - Product / Service; Exhibits132: JSR Life Sciences LLC - Key offerings; Exhibits133: Lonza Group Ltd. - Overview; Exhibits134: Lonza Group Ltd. - Business segments; Exhibits135: Lonza Group Ltd. - Key news; Exhibits136: Lonza Group Ltd. - Key offerings; Exhibits137: Lonza Group Ltd. - Segment focus; Exhibits138: Merck KGaA - Overview; Exhibits139: Merck KGaA - Business segments; Exhibits140: Merck KGaA - Key news; Exhibits141: Merck KGaA - Key offerings; Exhibits142: Merck KGaA - Segment focus; Exhibits143: Miltenyi Biotec B.V. and Co. KG - Overview; Exhibits144: Miltenyi Biotec B.V. and Co. KG - Product / Service; Exhibits145: Miltenyi Biotec B.V. and Co. KG - Key offerings; Exhibits146: Nanosomix Inc. - Overview; Exhibits147: Nanosomix Inc. - Product / Service; Exhibits148: Nanosomix Inc. - Key offerings; Exhibits149: NX PharmaGen Inc. - Overview; Exhibits150: NX PharmaGen Inc. - Product / Service; Exhibits151: NX PharmaGen Inc. - Key offerings; Exhibits152: QIAGEN NV - Overview; Exhibits153: QIAGEN NV - Product / Service; Exhibits154: QIAGEN NV - Key news; Exhibits155: QIAGEN NV - Key offerings; Exhibits156: Sarepta Therapeutics Inc - Overview; Exhibits157: Sarepta Therapeutics Inc - Product / Service; Exhibits158: Sarepta Therapeutics Inc - Key offerings; Exhibits159: System Biosciences LLC - Overview; Exhibits160: System Biosciences LLC - Product / Service; Exhibits161: System Biosciences LLC - Key offerings; Exhibits162: Thermo Fisher Scientific Inc. - Overview; Exhibits163: Thermo Fisher Scientific Inc. - Business segments; Exhibits164: Thermo Fisher Scientific Inc. - Key news; Exhibits165: Thermo Fisher Scientific Inc. - Key offerings; Exhibits166: Thermo Fisher Scientific Inc. - Segment focus; Exhibits167: Inclusions checklist; Exhibits168: Exclusions checklist; Exhibits169: Currency conversion rates for US$; Exhibits170: Research methodology; Exhibits171: Validation techniques employed for market sizing; Exhibits172: Information sources; Exhibits173: List of abbreviations